مبيعات تغيير تاريخ
Alaunos Therapeutics USD 2K 2K 2025-03
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Amgen USD 10.4B 300M 2026-09
Bayer EUR 10.05B 820M 2026-09
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
Biogen USD 2.8B 60M 2026-09
BioMarin Pharmaceutical USD 1.03B 40M 2026-09
Cipla INR 74.04B 2.85B 2026-09
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 2.6M 3.75M 2026-06
CSL USD 8.33B 4.79B 2025-12
Gilead Sciences USD 8.3B 500M 2026-09
GlaxoSmithKline GBP 8.89B 480M 2026-09
Grifols EUR 2B 306.7M 2026-03
Ionis Pharmaceuticals USD 243M 25M 2026-09
J&J USD 25.4B 89M 2026-09
Karyopharm Therapeutics USD 35.07M 987K 2026-03
Merck USD 18.1B 1.5B 2026-09
Novartis USD 14.52B 112M 2026-09
Pfizer USD 16.6B 1.57B 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 14.44B 2.49B 2026-09
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
Tectonic Therapeutic USD 0 0 2024-12
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
Vertex Pharmaceuticals USD 3.44B 110M 2026-09